Cabotib 40MG Tablet (30’s) is a prescription medication that contains Cabozantinib as its active ingredient, specifically formulated to treat certain types of cancer. This drug is primarily indicated for patients with advanced renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer) who have previously undergone other treatments. Cabozantinib works by inhibiting multiple receptor tyrosine kinases, which are involved in tumor growth and progression, thereby helping to slow down the spread of cancer cells. Each tablet contains 40 mg of Cabozantinib, and the medication is typically available in a pack of 30 tablets. The drug is designed to be taken orally, making it convenient for patients to incorporate into their daily routines. As a targeted therapy, Cabotib aims to improve patient outcomes by specifically addressing the pathways that contribute to cancer development, thus offering a more effective treatment option for those battling these serious conditions.